Mr. Ashish Malik reports

BEE VECTORING TECHNOLOGIES REPORTS SIGNIFICANT PROGRESS IN CR-7 SEED TREATMENT DEVELOPMENT FOR AGRICULTURE MARKETPLACE

Bee Vectoring Technologies International Inc. has made significant research and development advancements for its proprietary biological control agent clonostachys rosea strain CR-7 use as a seed treatment solution for soybeans. This breakthrough underscores the product's compatibility and safety on seeds, propelling it toward commercialization in the agriculture sector.

"Investing in this research is crucial for understanding the potential market for a CR-7 seed treatment product," said Ashish Malik, chief executive officer of Bee Vectoring. "This study allowed us to assess the effectiveness and safety of CR-7 on soybean seed, duration of action, and compatibility with other treatments. These are fundamental studies to support launching this product and further advancing our partnership opportunities."

"Two years of rigorous testing confirmed CR-7's exceptional safety profile on soybean seeds, showing no signs of toxicity or adverse effects on plant health," said Dr. Mason Newark, field technical manager at Bee Vectoring. "These results establish CR-7 as an excellent candidate for seed treatment, given its long shelf life, compatibility with other common seed treatment products and its safety for use on seeds."

The seed treatment market is a significant new revenue opportunity for the company. Through a future licensing agreement, Bee Vectoring could potentially reap significant annual royalties from this application.

"We continue to progress our collaborations with major global multinationals," said Mr. Malik. "These are potential partners looking to differentiate their seed treatment portfolio offerings in soybeans, a major global crop that is worth $155-billion (U.S.) annually and projected to reach $278-billion (U.S.) by 2031."

Research highlights include:

• Extended viability: CR-7 demonstrates a long shelf life once it is coated on soybean seeds. This is a key metric for seed treatments since seeds may not be planted for six to 12 months posttreatment, thus giving Bee Vectoring sales partners a strong value proposition and a robust product. This shelf life study in continuing.
• Compatibility with other seed treatments: Testing confirms CR-7's compatibility with other seed treatment products, including biologicals and chemical pesticides, ensuring it fits seamlessly into existing agricultural practices where multiple products are applied to the seed at the same time.
• Proven safety: Extensive safety tests show that CR-7 does not harm soybean plant germination or growth, maintaining plant health from seed through maturity.

Additional observations from Bee Vectoring's R&D team included:

• No observation of negative interactions between CR-7 and other microbes;
• CR-7 demonstrated significant compatibility with a number of major and commonly used fungicides;
• After nine months, CR-7 remains detectable in seedlings, demonstrating that it stays dormant until activated by a live host. This underscores its robust and enduring shelf life.

"Our ongoing R&D efforts continue to showcase the robustness of CR-7, with promising results indicating its effectiveness remains intact for up to nine months and potentially beyond," continued Dr. Newark. "Now we are testing for 20 months plus viability. What we've found so far that's particularly exciting is that CR-7 grows with the plant and creates a broader zone of protection from the seed stage to well into the roots and stems of the plant."

About Bee Vectoring Technologies International Inc.

Bee Vectoring, an agriculture technology company, is a market disruptor with a significant global market opportunity in the $240-billion crop protection and fertilizer market. Bee Vectoring has pioneered a natural precision agriculture system that replaces chemical pesticides and wasteful plant protection product spray applications by delivering biological pesticide alternatives to crops using commercially grown bees. Bee Vectoring's award-winning technology, precision vectoring, is completely harmless to bees and allows minute amounts of naturally derived pesticides (called biologicals) to be delivered directly to blooms, providing improved crop protection and yield results than traditional chemical pesticides -- and improving the health of the soil, the microbiome and the environment. Currently, Bee Vectoring has over 55 granted patents, many more patents pending in all major agricultural countries worldwide and has U.S. Environmental Protection Agency registration of its Vectorite with CR-7 (EPA registration No. 90641-2) for sale as a registered biological fungicide for use on the labelled crops.

We seek Safe Harbor.